Cigna Group (NYSE:CI) Stock Keeps Outperform Rating at Royal Bank Of Canada

Cigna Group (NYSE:CI)‘s stock had its “outperform” rating reaffirmed by Royal Bank Of Canada in a research report issued to clients and investors on Thursday, Benzinga reports. They presently have a $337.00 price target on the health services provider’s stock. Royal Bank Of Canada’s target price would indicate a potential upside of 25.11% from the company’s previous close.

CI has been the topic of a number of other research reports. Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a report on Thursday, August 27th. Raymond James Financial downgraded Cigna Group from a “strong-buy” rating to an “outperform” rating and lowered their price target for the company from $350.00 to $320.00 in a research report on Monday, August 3rd. Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, September 26th. Evercore assumed coverage on shares of Cigna Group in a research report on Wednesday, September 9th. They issued an “in-line” rating and a $290.00 price objective for the company. Finally, Barclays lifted their price objective on Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Fifteen equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $337.10.

Cigna Group Stock Performance

NYSE:CI opened at $269.37 on Thursday. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. Cigna Group has a 12 month low of $239.51 and a 12 month high of $315.47. The firm has a market capitalization of $71.18 billion, a PE ratio of 11.19, a price-to-earnings-growth ratio of 0.93 and a beta of 0.31. The business’s fifty day moving average price is $279.53 and its 200 day moving average price is $280.55.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. The company had revenue of $71.56 billion for the quarter, compared to analysts’ expectations of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same quarter last year, the company earned $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, sell-side analysts anticipate that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Insider Activity

In related news, insider Nicole Jones sold 19,436 shares of the business’s stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total value of $5,369,583.72. Following the sale, the insider directly owned 27,256 shares in the company, valued at $7,530,015.12. The trade was a 41.63% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the sale, the insider owned 5,053 shares of the company’s stock, valued at $1,435,304.65. This trade represents a 10.88% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 22,730 shares of company stock valued at $6,293,359. Insiders own 0.60% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of CI. QRG Capital Management Inc. increased its holdings in shares of Cigna Group by 35.1% in the 2nd quarter. QRG Capital Management Inc. now owns 22,694 shares of the health services provider’s stock valued at $6,256,000 after purchasing an additional 5,902 shares during the period. Envestnet Portfolio Solutions Inc. raised its holdings in shares of Cigna Group by 45.9% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 19,015 shares of the health services provider’s stock worth $5,242,000 after acquiring an additional 5,985 shares in the last quarter. Envestnet Asset Management Inc. grew its stake in Cigna Group by 43.2% in the second quarter. Envestnet Asset Management Inc. now owns 676,904 shares of the health services provider’s stock valued at $186,609,000 after purchasing an additional 204,285 shares in the last quarter. Anchor Investment Management LLC lifted its stake in shares of Cigna Group by 7.5% in the second quarter. Anchor Investment Management LLC now owns 3,224 shares of the health services provider’s stock worth $889,000 after buying an additional 226 shares during the last quarter. Finally, Sequoia Financial Advisors LLC grew its stake in Cigna Group by 14.8% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 12,092 shares of the health services provider’s stock valued at $3,333,000 after buying an additional 1,563 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

More Cigna Group News

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna introduced its “Lead to One” strategy, emphasizing personalized care, clinical expertise, data and artificial intelligence. Management expects these capabilities to support a 10%–14% adjusted EPS compound annual growth rate through 2030, providing a new long-term framework for investors. The Cigna Group Hosts 2026 Investor Day
• Positive Sentiment: The company plans to invest $3 billion in a multiyear modernization and productivity initiative designed to improve workflows, lower operating friction and strengthen performance. Although the spending could weigh on near-term results, investors may view it as support for longer-term margin and earnings growth. Cigna to invest $3 billion in a multiyear initiative
• Positive Sentiment: New CEO Brian Evanko is placing greater emphasis on specialty pharmacy and complex-care services within Evernorth. The focus targets areas where healthcare costs are rising and could create growth opportunities through higher-value clinical and pharmacy capabilities. Cigna to Ramp Up Investments in Specialty Pharmacy and Complex Care
• Positive Sentiment: Cigna’s international health business announced an exclusive agreement with UnitedHealthcare Global, potentially expanding distribution and international capabilities. Cigna International agreement with UnitedHealthcare Global
• Neutral Sentiment: Analysts continue to show a generally favorable view, with Cigna receiving a consensus “Moderate Buy” rating. However, the key question is whether the new specialty-pharmacy strategy can translate into sustained earnings growth under the new CEO. Cigna consensus rating
• Negative Sentiment: Cigna reaffirmed 2026 adjusted EPS guidance of approximately $30.45, slightly below the $30.51 consensus, while setting revenue guidance at $280 billion versus an estimated $287.2 billion. The revenue shortfall may limit near-term upside despite the stronger long-term outlook. Cigna long-term targets and 2026 guidance

Cigna Group Company Profile

The Cigna Group (NYSE: CI) is a global health company that provides health care and related services to individuals, employers, government organizations and health plans. Its operations are primarily organized through Cigna Healthcare and Evernorth Health Services, which together address health coverage, pharmacy services, care delivery and benefit management.

Cigna Healthcare offers medical, dental, behavioral health, disability and other benefits, with a focus on employer-sponsored and individual health plans in the United States as well as international health services.